ERBB2 and breast carcinoma: In mice with ErbB-2-induced breast cancer, PTP1B deficiency or inhibition delayed tumor progression, protected against lung metastases, and triggered earlier apoptosis by down-regulating both Ras-MAPK and PI3K-Akt signaling pathways [46].